On  February 1, 2022, Pfizer/BioNTec requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for their covid jabs to babies and children aged 6 months to 4 years. The EUA will be for a two-dose regimen, with the possibility of a third booster. Two injections have demonstrated to be ineffective in 2 … Continue reading Pfizer Seeking Approval For Covid Jab In Children Under 5